Rituximab maintenance after autologous stem‐cell transplantation in patients with mantle cell lymphoma, final result of the LyMA trial conducted on behalf the LYSA group. (June 2017)

• Record Type: Journal Article
• Authors: Le Gouill, S.; Thieblemont, C.; Oberic, L.; Moreau, A.; Bouabdallah, K.; Dartigeas, C.; Damaj, G.; Gastinne, T.; Ribrag, V.; Feugier, P.; Casasnovas, O.; Zerazhi, H.; Haioun, C.; Maisonneuve, H.; Van Den Neste, E.; Tournilhac, O.; Le Dû, K.; Morschhauser, F.; Cartron, G.; Fornecker, L.; Salles, G.; Tilly, H.; Lamy, T.; Gressin, R.; Hermine, O.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 209
• Page End: 209
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_74
• Languages: English
• ISSNs: 0278-0232